[TLX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
29-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -20.02%
YoY- -99.81%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/15 CAGR
Revenue 24,047 2,910 1,607 1,818 0 0 0 -
PBT -70,703 -37,046 -25,096 -17,125 -5,190 -3,143 -66 170.70%
Tax 188 -4,532 -6,795 -6,756 -5,190 -76 -8 -
NP -70,891 -32,514 -18,301 -10,370 -5,190 -3,143 -66 170.81%
Tax Rate - - - - - - - -
Total Cost 94,938 35,424 19,908 12,187 5,190 3,143 66 182.34%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/15 CAGR
NP Margin -294.80 -1,117.32 -1,138.83 -570.54 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/15 CAGR
EPS -0.23 -0.12 -0.07 -0.05 -0.03 -1.28 0.00 -
EPS Diluted -0.23 -0.12 -0.07 -0.05 -0.03 -1.28 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.